Class A · CUSIP 56600D107 · who reports it, how much, and how much it matters to them
24 of the 720 hedge fund managers we track reported shares of Maravai Lifesciences Holdings, Inc. (Nasdaq: MRVI) on Form 13F for 30 June 2026. Between them they reported USD 258m. The largest position belongs to Braidwell, at USD 54m. The manager with the most riding on it is 12 West Capital Management, where it is 8.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Braidwell12 funds on PPLI.com | USD 54m | 2.0% |
| 2 | 12 West Capital Management5 funds on PPLI.com | USD 44m | 8.2% |
| 3 | Millennium Management6 funds on PPLI.com | USD 41m | 0.0% |
| 4 | Renaissance Technologies13 funds on PPLI.com | USD 29m | 0.0% |
| 5 | Two Sigma Investments35 funds on PPLI.com | USD 14m | 0.0% |
| 6 | Citadel Advisors32 funds on PPLI.com | USD 13m | 0.0% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 13m | 0.0% |
| 8 | Philosophy Capital Management4 funds on PPLI.com | USD 12m | 0.6% |
| 9 | Tudor Investment Corporation10 funds on PPLI.com | USD 12m | 0.0% |
| 10 | Marshall Wace LLP84 funds on PPLI.com | USD 9.2m | 0.0% |
| 11 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 8m | 0.3% |
| 12 | Verition Fund Management3 funds on PPLI.com | USD 4.9m | 0.0% |
| 13 | Aquatic Capital Management3 funds on PPLI.com | USD 1.2m | 0.0% |
| 14 | Caxton Associates6 funds on PPLI.com | USD 702,000 | 0.0% |
| 15 | Entrypoint Capital1 fund on PPLI.com | USD 594,000 | 0.1% |
| 16 | Graham Capital Management18 funds on PPLI.com | USD 576,000 | 0.0% |
| 17 | Engineers Gate Manager1 fund on PPLI.com | USD 487,000 | 0.0% |
| 18 | Voleon Capital Management13 funds on PPLI.com | USD 466,000 | 0.0% |
| 19 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 415,000 | 0.0% |
| 20 | Magnetar Financial93 funds on PPLI.com | USD 224,000 | 0.0% |
| 21 | Prelude Capital Management9 funds on PPLI.com | USD 163,000 | 0.0% |
| 22 | Squarepoint Ops7 funds on PPLI.com | USD 128,000 | 0.0% |
| 23 | Oxford Asset Management LLP2 funds on PPLI.com | USD 118,000 | 0.1% |
| 24 | Hudson Bay Capital Management8 funds on PPLI.com | USD 77,376 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | 12 West Capital Management | USD 44m | 8.2% |
| 2 | Braidwell | USD 54m | 2.0% |
| 3 | Philosophy Capital Management | USD 12m | 0.6% |
| 4 | Arrowmark Colorado Holdings | USD 8m | 0.3% |
| 5 | Entrypoint Capital | USD 594,000 | 0.1% |
| 6 | Oxford Asset Management LLP | USD 118,000 | 0.1% |
| 7 | Aquatic Capital Management | USD 1.2m | 0.0% |
| 8 | Renaissance Technologies | USD 29m | 0.0% |
| 9 | Verition Fund Management | USD 4.9m | 0.0% |
| 10 | Tudor Investment Corporation | USD 12m | 0.0% |
Maravai Lifesciences Holdings, Inc. trades under the symbol MRVI on the Nasdaq. Its CUSIP, the code used on Form 13F, is 56600D107.
24 of the 720 hedge fund managers PPLI.com tracks reported Maravai Lifesciences Holdings, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Braidwell (USD 54m), 12 West Capital Management (USD 44m), Millennium Management (USD 41m), Renaissance Technologies (USD 29m) and Two Sigma Investments (USD 14m).
24 managers in our coverage reported it, and between them they run 436 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
12 West Capital Management, where the position was 8.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Maravai Lifesciences Holdings, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.